🔎 Trials Near Me

Gara Jalqabaatti › Kansa Selii Skwaamoo Mataa fi Morma › Maryland › Baltimore

Qorannoo klinikaalii Kansa Selii Skwaamoo Mataa fi Morma Baltimore, MD keessatti

Qorannoo 15 Kansa Selii Skwaamoo Mataa fi Morma f Baltimore fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.

Takkalaa qorannoo (Ingiliffa)

Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →

FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC

Namoota walitti qabaa jiraSadarkaa 2/3
  • Site #0112, Baltimore
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT06788990

Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors

Namoota walitti qabaa jiraSadarkaa 1
  • Exelixis Clinical Site #14, Baltimore
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 01-Onk-2026 · NCT05176483

Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment

Namoota walitti qabaa jiraSadarkaa 3
  • University of Maryland/Greenebaum Cancer Center, Baltimore
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 01-Onk-2026 · NCT06589804

A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer

Namoota walitti qabaa jiraSadarkaa 3
  • University of Maryland Greenebaum Cancer Center, Baltimore
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT07276399

A Study of Amivantamab Alone or in Addition to Other Treatment Agents in Participants With Head and Neck Cancer

Namoota walitti qabaa jiraSadarkaa 1/2
  • University of Maryland School of Medicine, Baltimore
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT06385080

Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma

Namoota walitti qabaa jiraSadarkaa 2
  • University of Maryland/Greenebaum Cancer Center, Baltimore
  • UM Baltimore Washington Medical Center/Tate Cancer Center, Glen Burnie · Miili 9 fagaatti
Umuriin 18 hanga 79 · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT04671667

Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery

Namoota walitti qabaa jiraSadarkaa 2
  • Greater Baltimore Medical Center, Baltimore
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 14-Ful-2026 · NCT02734537

Study of Volrustomig as Monotherapy or in Combination With Anti- Cancer Agents in Participants With Advanced/Metastatic Solid Tumors

Namoota walitti qabaa jiraSadarkaa 2
  • Research Site, Baltimore
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 11-Ful-2026 · NCT06535607

A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)

Namoota walitti qabaa jiraQorannoo ilaalaa
  • University of Maryland, Baltimore
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 03-Ful-2026 · NCT06163534

Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer

Namoota walitti qabaa jiraSadarkaa 2
  • Greater Baltimore Medical Center, Baltimore
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 17-Hag-2026 · NCT06532279

Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors

Namoota walitti qabaa jiraSadarkaa 1
  • Johns Hopkins Hospital /ID# 254056, Baltimore
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 04-Wax-2026 · NCT04777994

A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma

Namoota walitti qabaa jiraSadarkaa 3
  • University of Maryland, Baltimore
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 09-Elb-2026 · NCT06064877

A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation

Namoota walitti qabaa jiraSadarkaa 1
  • Johns Hopkins - Sidney Kimmel Comprehensive Cancer Center, Baltimore
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 13-Gur-2026 · NCT06778863

Selective Adjuvant Therapy for HPV-mediated Oropharynx SCCs Based on Residual Circulating Tumor DNA Levels (SAVAL)

Namoota walitti qabaa jiraSadarkaa 2
  • Maryland Proton Treatment Center, Baltimore
  • University of Maryland Greenebaum Cancer Center, Baltimore
  • Baltimore Washington Medical Center, Glen Burnie · Miili 9 fagaatti
  • fi 1 dabalataa
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 10-Sad-2025 · NCT06088381

A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer

Namoota walitti qabaa jiraSadarkaa 1/2
  • Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 04-Sad-2025 · NCT05902988

Qorannoo Kansa Selii Skwaamoo Mataa fi Morma magaalota biroo keessatti

Qorannoo biroo Baltimore keessatti

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.